Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma

• Seulki Cho,

  Affiliations Department of Functional Genomics, University of Science & Technology, Daejeon, Republic of Korea, Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon, Republic of Korea

  ⨯
• Tae Sup Lee,

  Affiliation Division of RI Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

  ⨯
• In Ho Song,

  Affiliation Division of RI Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

  ⨯
• A-Ram Kim,

  Affiliation Division of Basic Radiation Bioscience, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea

  ⨯
• Yoon-Jin Lee,

  Affiliation Division of Basic Radiation Bioscience, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea

  ⨯
• Haejung Kim,

  Affiliation Department of Biology, Kangwon National University, Chuncheon, Republic of Korea

  ⨯
• Haein Hwang,

  Affiliation Department of Systems Immunology, Kangwon National University, Chuncheon, Republic of Korea

  ⨯
• Mun Sik Jeong,

  Affiliation Department of Systems Immunology, Kangwon National University, Chuncheon, Republic of Korea

  ⨯
• Seung Goo Kang,

  Affiliation Department of Systems Immunology, Kangwon National University, Chuncheon, Republic of Korea

  ⨯
• Hyo Jeong Hong

  * E-mail: hjhong@kangwon.ac.kr

  Affiliations Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon, Republic of Korea, Department of Systems Immunology, Kangwon National University, Chuncheon, Republic of Korea

  ⨯